Carcinoma of the lung

References

• Martini N, Flehinger BJ, Bains MS, et al. Management of stage III disease: alternate approaches to the management of mediastinal adenopathy. In: DeLarue NC, Eschapasse H, eds. Lung cancer. Philadelphia: WB Saunders, 1985: 108–20 (International trends in general thoracic surgery, vol 1)
   Google Scholar
• Meyer JA. Five-year survival in treated stage I and II small cell carcinoma of the lung. Ann Thorac Surg 1986: 42(6): 668–9
   PubMed Web of Science ®Google Scholar
• Trybula M, Taylor SG, Bonomi P, et al. Preoperative simultaneous cisplatin/5-fluorouracil and radiotherapy in clinical stage III, non-small cell bronchogenic carcinoma. Proc Am Soc Clin Oncol 1985: 4(3): 182–5
   Google Scholar
• The Lung Cancer Study Group, preoperative chemoradiotherapy in stage III non-small cell lung cancer (NSCLC): a phase II study. (Abstr 728) Proc Am Soc Clin Oncol 1987: 6(3): 185
   Google Scholar
• Holmes EC. Current status of adjuvant chemotherapy in the treatment of non-small cell lung cancer. In: DeVita VT, Hellman S, Rosenberg SA, eds. Important advances in oncology 1988. Philadelphia: JB Lippincott. 1988: 259–72
   Google Scholar
• Gall MH, Eagan RT, Feld R, et al. Prognostic factors in patients with resected stage I non-small cell lung cancer: a report from the Lung Cancer Study Group, Cancer 1964: 54(9): 1802–13
   Google Scholar
• Pearson FG, DeLarue NC, Ilves R, et al. Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung. J Thorac Cardlovasc Surg 1982: 83(1): 1–11
   PubMed Web of Science ®Google Scholar
• Martini N, Flehinger BJ, Zaman MB, et al. Results of resection in non-oat cell carcinoma of the lung with mediastinal lymph node metastases. Ann Surg 1983: 98(3): 386–97
   Google Scholar
• Holmes EC, Gail M. Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large-cell undifferentiated carcinoma. J Clin Oncol 1986: 4(5): 710–5
   PubMed Web of Science ®Google Scholar
• Newman SB, DeMeester TR, Golomb HM, et al. Treatment of modified Stage II (T1 N1 M0, T2 N1 M0) non-small cell bronchogenic carcinoma: a combined modality approach. J Thorac Cardiovasc Surg 1983: 86(2): 180–5
   PubMed Web of Science ®Google Scholar
• Mountain CF. A new international staging system for lung cancer. Chest 1986: 89(4 Suppl): 225–33S
   Web of Science ®Google Scholar
• Naruke T, Suemasu K, Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg 1978: 76(6): 832–9
   PubMed Web of Science ®Google Scholar
• Melamed MR, Flehinger BJ, Zaman MB. Impact of early detection on the clinical course of lung cancer. Surg Clin North Am 1987: 67(5): 909–24
   PubMed Web of Science ®Google Scholar
• Rosa UW, Prolla JC, Gastal ES. Cytology in diagnosis of cancer affecting the lung: results in 1,000 consecutive patients. Chest 1973: 63(2): 203–7
   PubMed Web of Science ®Google Scholar
• Kies MS, Baker AW, Kennedy PS. Radionuclide scans in staging of carcinoma of the lung. Surg Gynecol Obstet 1978: 147(2): 175–6
   PubMedGoogle Scholar
• Nathan MH, Collins VP, Adams RA. Differentiation of benign and malignant pulmonary nodules by growth rate. Radiology 1962: 79(Aug): 221–32
   PubMedGoogle Scholar
• Jaubert F, Dulmet-Breader E. Controversial aspects of histogenies. In: DeLarue, Eschapasse, eds,1 pp 3–26
   Google Scholar
• Lillington GA. The solitary pulmonary nodule—1974. Am Rev Respir Dis 1974: 110(6): 699–707
   PubMedGoogle Scholar
• DeMeester TR, Albertucci M. Clinical characteristics of stage I disease. In: Bitran JD, Golomb HM, Little AG, et al, eds. Lung cancer: a comprehensive treatise. Orlando, FL: Grune & Stratton, 1988: 135–48
   Google Scholar
• Brewer LA. Patterns of survival in lung cancer. Chest 1977: 71(5): 644–50
   PubMed Web of Science ®Google Scholar
• Massen W. Accuracy of mediastinoscopy. In: DeLarue, Eschapasse, eds,1 pp 42–53
   Google Scholar
• Baron RL, Levitt RG, Sagel SS, et al. Computed tomography in the preoperative evaluation of bronchogeniC carcinoma. Radiology 1982: 145(3): 727–32
   PubMed Web of Science ®Google Scholar
• Ferguson MK, Little AG, Golomb HM, et al. The role of adjuvant therapy after resection of T1 N1 M0 and T2 N1 M0 non-small cell lung cancer. J Thorac Cardiovasc Surg 1986: 91(3): 344–9
   PubMed Web of Science ®Google Scholar
• Friedman PJ, Feigin DS, Liston SE, et al. Sensitivity of chest radiography, computed tomography, and gallium scanning to metastasis of lung carcinoma. Cancer 1984: 54(7): 1300–6
   PubMed Web of Science ®Google Scholar
• Levitt RG, Glazer HS, Roper CL, et al. Magnetic resonance imaging of medtastinal and hilar masses: comparison with CT. AJR 1985: 145(1): 9–14
   PubMed Web of Science ®Google Scholar
• Nohl HC. An investigation into the lymphatic and vascular spread of carcinoma of the bronchus. Thorax 1956: 2(4): 172–85
   Google Scholar
• Schreinemakers HH, Joosten HJ, Mravunac M, et al. Parasternal mediastinoscopy. Assessment of operability in left upper lobe lung cancer: a prospective analysis. J Thorac Cardiovasc Surg 1988: 95(2): 298–302
   PubMed Web of Science ®Google Scholar
• Kirsh MM, Rotman H, Argenta L, et al. Carcinoma of the lung: results of treatment over ten years. Ann Thorac Surg 1976: 21(5): 371–7
   PubMed Web of Science ®Google Scholar
• Radke JR, Conway WA, Eyler WR, et al. Diagnostic accuracy in peripheral lung lesions: factors predicting success with flexible fiberoptic bronchoscopy. Chest 1979: 76(2): 176–9
   PubMed Web of Science ®Google Scholar
• Shure D, Fedullo PF. The role of transcarinal needle aspiration in the staging of bronchogenic carcinoma. Chest 1984: 86(5): 693–6
   PubMed Web of Science ®Google Scholar
• Gibney RT, Man GC, King EG, et al. Aspiration biopsy in the diagnosis of pulmonary disease. Chest 1981: 80(3): 300–3
   PubMed Web of Science ®Google Scholar
• Wernly JA, DeMeester TR. Preoperative assessment of patients undergoing lung resection for cancer. In: Roth JA, Ruckdeschel JC, Weisenburger TH, eds. Thoracic oncology. Philadelphia: WB Saunders, 1988: 156–76
   Google Scholar
• Diener CF, Burrows B. Further observations on the course and prognosis of chronic obstructive lung disease. Am Rev Respir Dis 1975: 111 (6): 719–24
   PubMed Web of Science ®Google Scholar
• Fries JF. Aging, natural death, and the compression of morbidity. N Engl J Med 1980: 303(3): 130–5
   PubMed Web of Science ®Google Scholar
• Jensik RJ. The extent of resection for localized lung cancer: segmental resection. In: Kittle CF, ed. Current controversies in thoracic surgery. Philadelphia: WB Saunders, 1986: 175–82
   Google Scholar
• Hilaris BS, Martini N, Wong GY, et al. Treatment of superior sulcus tumor (Pancoast tumor). Surg Clin North Am 1987: 67(5): 965–77
   PubMed Web of Science ®Google Scholar
• Plehler JM, Pairolero PC, Weiland LH, et al. Bronchogenic carcinoma with chest wall invasion: factors affecting survival following en bloc resection. Ann Thorac Surg 1982: 34(6): 684–91
   PubMed Web of Science ®Google Scholar
• Iascone C, Demeester TR, Albertucci M, et al. Local recurrence of resectable non-oat cell carcinoma of the lung: a warning against conservative treatment for NO and N1 disease. Cancer 1986: 57(3): 471–6
   PubMed Web of Science ®Google Scholar
• Matthews MJ, Kanhouwa S, Pickren J, et al. Frequency of residual and metastatic tumor in patients undergoing curative Surgical resection for lung cancer. Cancer Chemother Rep 1973: 4(2): 63–7
   Google Scholar
• Shapshzy SM, Dumon JF, Beamis JF Jr. Endoscopic treatment of tracheobronchial malignancy: experience with Nd-YAG and CO2 lasers in 506 operations. Otolaryngol Head Neck Surg 1985: 93(2): 205–10
   PubMed Web of Science ®Google Scholar
• Krish MM, Rotman H, Behrendt DM, et al. Complications of pulmonary resection. Ann Thorac Surg 1975: 20(2): 215–36
   PubMed Web of Science ®Google Scholar
• Shields TW. preoperative radlation therapy in the treatment of bronchial carcinoma. Cancer 1972: 30(5): 1388–94
   PubMed Web of Science ®Google Scholar
• The Lung Cancer Study Group. Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung. N Engl J Med 1986: 315(22): 1377–81
   PubMed Web of Science ®Google Scholar
• Moores DW, Miller SJ Jr, McKneally MF. Lung cancer: a surgeon's approach. Curr Probl Surg 1987: 24(11): 679–758
   PubMedGoogle Scholar
• Lad T, Weisenburger T. Adjuvant therapy of incompletely resected non-small cell bronchogenic carcinoma: a Lung Cancer Study Group trial. Proc Am Soc Clin Oncol 1985: (3): 179–83
   Google Scholar
• Taylor SG 4th, Trybula M, Bonomi PD, et al. Simultaneous cisplatin fluorouracil infusion and radiation followed by surgical resection in regionally localized stage III, non-small cell lung cancer. Ann Thorac Surg 1987: 43(1): 87–91
   PubMed Web of Science ®Google Scholar
• Rosenberg SA, Lotze MT, Muul LM, et al. Observations on the systemic administration of autologous lymphokine- activated killer cells and recombinant interleukin-2 to patients With metastatic cancer. N Engl J Med 1985: 313(23): 1485–92
   PubMed Web of Science ®Google Scholar
• Rosenberg SA. Immunotherapy of patients with advanced cancer using interleukin-2 alone or in combination with lymphokine activated killer cells. In: DeVita, et al, eds,5 pp 217–58
   Google Scholar
• Bondadoma G, Valgussa P. Role of chemotherapy in stage I breast cancer. In: DeVita VT, Hellman S, Rosenberg SA, eds. Important advances in oncology Philadelphia: JB Lippincott, 1989: 151–60
   Google Scholar
• Gallino P. Experimental systems and invasion. In: Weiss L, Gilbert H, eds. Bone metastasis. Boston: GK Hall, 1980: 24–38
   Google Scholar
• Phillips JH, Le AM, Lanier LL. Natural killer cells activated in a human mixed lymphocyte response culture identified by expression of Leu-11 and class II histocompatibility antigens. J Exp Med 1964: 159(4): 993–1008
   Google Scholar
• Tirindelli-Danesi D, Teodoral L, Mauro F, et al. Prognostic significance of flow cytometry in lung cancer: a 5-year study. Cancer 1987: 60(4): 844–51
   PubMed Web of Science ®Google Scholar
• Fisher RJ, Bader JP, Papa TS. Oncogenes and the mitogenic signal pathway. In DeVita et al, eds,49 pp 3–27
   Google Scholar
• Di Paola M, Bertolotti A, Colizza S, et al. Histology of bronchial carcinoma and regional lymph nodes as putative immune response of the host to the tumor. J Thorac Cardiovasc Surg 1977: 73(4): 531–7
   PubMed Web of Science ®Google Scholar
• Kitsichi M, Asamoto H, Izumi T, et al. Histological classification of regional lymph nodes in relation to postoperative survival in primary lung cancer. Hum Pathol 1981: 12(11): 1000–5
   PubMed Web of Science ®Google Scholar
• Fraire AE, Roggli VL, Vollmer RT, et al. Lung cancer heterogeneity: prognostic implications. Cancer 1987: 60(3): 370–5
   PubMed Web of Science ®Google Scholar
• Salmon SE. Human tumor colony assay and chemosensitivity testing. Cancer Treat Rep 1964: 68(1): 117–25
   Google Scholar